SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0000885590-22-000042
Filing Date
2022-09-02
Accepted
2022-09-02 16:30:44
Documents
16
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A bhc-20220630.htm   iXBRL 10-Q/A 987019
2 EX-31.1 exhibit311q2a2022.htm EX-31.1 10198
3 EX-31.2 exhibit312q2a2022.htm EX-31.2 10220
4 EX-32.1 exhibit321q2a2022.htm EX-32.1 6681
5 EX-32.2 exhibit322q2a2022.htm EX-32.2 6724
  Complete submission text file 0000885590-22-000042.txt   1341909

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhc-20220630.xsd EX-101.SCH 1983
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhc-20220630_lab.xml EX-101.LAB 32100
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhc-20220630_pre.xml EX-101.PRE 16852
10 EXTRACTED XBRL INSTANCE DOCUMENT bhc-20220630_htm.xml XML 15408
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-14956 | Film No.: 221225563
SIC: 2834 Pharmaceutical Preparations